Nightingale Health Oyj Logo

Nightingale Health Oyj

Analyzes blood biomarkers from one sample for chronic disease risk for healthcare organizations.

HEALTH | ST

Overview

Corporate Details

ISIN(s):
FI4000490875
LEI:
743700WUIPC24LVMLO66
Country:
Finland
Address:
Mannerheimintie 164a, FI-00300 HELSINKI
Sector:
Human health and social work activities
Industry:
Other human health activities

Description

Nightingale Health Oyj is a health technology company focused on preventative healthcare. It operates a proprietary health data platform that analyzes blood biomarkers to provide risk detection for multiple chronic diseases from a single sample. The company's core products, the Health Check and Remote Health Check, are designed for a diverse clientele including healthcare providers, insurance companies, governments, public health systems, telehealth services, and the medical research community. Nightingale Health's mission is to build a more sustainable and equitable healthcare system by enabling early risk detection and proactive health management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 16:10
AGM Information
Nightingale Health Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytym…
Finnish 8.1 KB
2025-11-06 16:10
AGM Information
Resolutions of the Annual General Meeting and the Board of Directors' organizat…
English 8.8 KB
2025-10-02 14:30
Pre-Annual General Meeting Information
Kutsu Nightingale Health Oyj:n varsinaiseen yhtiökokoukseen
Finnish 27.4 KB
2025-10-02 14:30
Pre-Annual General Meeting Information
Notice to the Annual General Meeting of Nightingale Health Plc
English 29.8 KB
2025-10-02 08:00
Report Publication Announcement
Nightingale Healthin vuosikertomus tilikaudelta 2024-2025 on julkaistu
Finnish 3.8 KB
2025-10-02 08:00
Report Publication Announcement
Nightingale Health's Annual Report for financial year 2024-2025 has been publis…
English 3.7 KB
2025-09-18 08:00
Earnings Release
Nightingale Health Oyj tilinpäätöstiedote 1.7.2024-30.6.2025
Finnish 24.4 KB
2025-09-18 08:00
Earnings Release
Nightingale Health Plc Financial Statements Release 1 July 2024 - 30 June 2025
English 23.0 KB
2025-09-16 09:25
Regulatory Filings
Sisäpiiritieto: Nightingale Health valittu palveluntarjoajaksi 2,4 miljoonan eu…
Finnish 4.2 KB
2025-09-16 09:25
Regulatory Filings
Inside information: Nightingale Health selected as multiomics provider for EUR …
English 4.0 KB
2025-09-08 15:10
Share Issue/Capital Change
Nightingale Health Oyj:n EMP-osakkeiden muunto B-sarjan osakkeiksi
Finnish 2.8 KB
2025-09-08 15:10
Share Issue/Capital Change
Conversion of Nightingale Health Plc's EMP shares to Series B shares
English 2.8 KB
2025-07-02 11:55
Earnings Release
Sisäpiiritieto, tulosvaroitus: Nightingale Healthin liikevaihto kasvaa, ja oika…
Finnish 4.1 KB
2025-07-02 11:55
Earnings Release
Inside information, profit warning: Nightingale Health's revenue increases, and…
English 4.0 KB
2025-05-02 14:45
Board/Management Information
Changes in Nightingale Health Plc's..
Finnish 3.8 KB

Automate Your Workflow. Get a real-time feed of all Nightingale Health Oyj filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nightingale Health Oyj

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nightingale Health Oyj via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

LABCORP HOLDINGS INC. Logo
Provides diagnostic lab testing and biopharma drug development services for healthcare clients.
United States of America
LH
LabGenomics. Co., Ltd. Logo
Provider of NGS-based molecular diagnostics for prenatal, cancer, and direct-to-consumer testing.
South Korea
084650
Lucid Diagnostics Inc. Logo
Offers a non-invasive DNA test for early detection of esophageal precancer in at-risk patients.
United States of America
LUCD
Develops AI-enhanced blood tests to evaluate indeterminate lung nodules for early cancer detection.
United States of America
LLAI
MDxHealth SA Logo
Advanced molecular diagnostics for urologic diseases, focusing on personalized prostate cancer care.
Belgium
MDXH
Medical Ikkou Group Co.,Ltd. Logo
Operates dispensing pharmacies and manages residential nursing and long-term care facilities.
Japan
3353
Medirom Healthcare Technologies Inc. Logo
Operates relaxation salons integrating hands-on wellness with digital health technology.
United States of America
MRM
METACARE Co., Ltd. Logo
South Korea
118000
Metrics in Balance N.V. Logo
Develops posture clinics, dental splints & DNA tests for European consumers & professionals.
Belgium
MLMIB
MONA YONGPYONG CO.,LTD  Logo
Operates a comprehensive South Korean resort with year-round ski, golf, and leisure facilities.
South Korea
070960

Talk to a Data Expert

Have a question? We'll get back to you promptly.